ATE411803T1 - Verfahren zur behandlung von schwerer herzinsuffizienz und medikament dafür - Google Patents

Verfahren zur behandlung von schwerer herzinsuffizienz und medikament dafür

Info

Publication number
ATE411803T1
ATE411803T1 AT04713672T AT04713672T ATE411803T1 AT E411803 T1 ATE411803 T1 AT E411803T1 AT 04713672 T AT04713672 T AT 04713672T AT 04713672 T AT04713672 T AT 04713672T AT E411803 T1 ATE411803 T1 AT E411803T1
Authority
AT
Austria
Prior art keywords
medication
therefor
heart failure
severe heart
treating severe
Prior art date
Application number
AT04713672T
Other languages
English (en)
Inventor
Atsushi Ozaki
Yosuke Maki
Osamu Sato
Yoshitaka Yamamura
Original Assignee
Otsuka Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=32908667&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE411803(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Otsuka Pharma Co Ltd filed Critical Otsuka Pharma Co Ltd
Application granted granted Critical
Publication of ATE411803T1 publication Critical patent/ATE411803T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D223/16—Benzazepines; Hydrogenated benzazepines

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT04713672T 2003-02-24 2004-02-23 Verfahren zur behandlung von schwerer herzinsuffizienz und medikament dafür ATE411803T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US44887803P 2003-02-24 2003-02-24

Publications (1)

Publication Number Publication Date
ATE411803T1 true ATE411803T1 (de) 2008-11-15

Family

ID=32908667

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04713672T ATE411803T1 (de) 2003-02-24 2004-02-23 Verfahren zur behandlung von schwerer herzinsuffizienz und medikament dafür

Country Status (23)

Country Link
US (2) US7423032B2 (de)
EP (2) EP1596868B1 (de)
JP (2) JP4771937B2 (de)
KR (1) KR100706727B1 (de)
CN (1) CN100577171C (de)
AR (1) AR043259A1 (de)
AT (1) ATE411803T1 (de)
AU (2) AU2004212842B9 (de)
BR (1) BRPI0405657A (de)
CA (1) CA2493475A1 (de)
CY (1) CY1108583T1 (de)
DE (1) DE602004017283D1 (de)
DK (1) DK1596868T3 (de)
ES (1) ES2315640T3 (de)
MX (1) MXPA05001623A (de)
MY (1) MY143740A (de)
NO (1) NO335369B1 (de)
PL (2) PL218069B1 (de)
PT (1) PT1596868E (de)
RU (2) RU2346689C2 (de)
SI (1) SI1596868T1 (de)
TW (1) TWI322689B (de)
WO (1) WO2004073716A1 (de)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7468390B2 (en) * 2002-01-17 2008-12-23 Novartis Ag Methods of treatment and pharmaceutical composition
TWI322689B (en) * 2003-02-24 2010-04-01 Otsuka Pharma Co Ltd Method for treating severe heart failure and medicament therefor
DE102005003632A1 (de) 2005-01-20 2006-08-17 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. Katheter für die transvaskuläre Implantation von Herzklappenprothesen
US20070213813A1 (en) 2005-12-22 2007-09-13 Symetis Sa Stent-valves for valve replacement and associated methods and systems for surgery
PL1968990T3 (pl) 2005-12-27 2015-06-30 Otsuka Pharma Co Ltd Rozpuszczalny w wodzie związek benzoazepinowy i jego kompozycja farmaceutyczna
JP5076327B2 (ja) * 2006-02-01 2012-11-21 味の素株式会社 分岐鎖アミノ酸の心不全適応
US7896915B2 (en) 2007-04-13 2011-03-01 Jenavalve Technology, Inc. Medical device for treating a heart valve insufficiency
MX2009012164A (es) * 2007-05-15 2009-12-09 Otsuka Pharma Co Ltd Metodos para utilizar antagonistas de vasopresina con agentes de quimioterapia con antraciclina para reducir la cardiotoxicidad y/o para mejorar la supervivencia.
TWI405574B (zh) * 2007-06-21 2013-08-21 Otsuka Pharma Co Ltd 藥學固體製劑及其製造方法
WO2011104269A1 (en) 2008-02-26 2011-09-01 Jenavalve Technology Inc. Stent for the positioning and anchoring of a valvular prosthesis in an implantation site in the heart of a patient
US9044318B2 (en) 2008-02-26 2015-06-02 Jenavalve Technology Gmbh Stent for the positioning and anchoring of a valvular prosthesis
US10856978B2 (en) 2010-05-20 2020-12-08 Jenavalve Technology, Inc. Catheter system
CA2799459A1 (en) 2010-05-25 2011-12-01 Jenavalve Technology Inc. Prosthetic heart valve and transcatheter delivered endoprosthesis comprising a prosthetic heart valve and a stent
JP5477413B2 (ja) * 2012-04-24 2014-04-23 味の素株式会社 分岐鎖アミノ酸の心不全適応
CN105491978A (zh) 2013-08-30 2016-04-13 耶拿阀门科技股份有限公司 用于假体瓣膜的径向可折叠框架及其制造方法
EP3270825B1 (de) 2015-03-20 2020-04-22 JenaValve Technology, Inc. Herzklappenprothesenzuführsystem
EP3632378B1 (de) 2015-05-01 2024-05-29 JenaValve Technology, Inc. Vorrichtung mit reduzierter herzschrittmacherrate bei herzklappenersatz
US11065138B2 (en) 2016-05-13 2021-07-20 Jenavalve Technology, Inc. Heart valve prosthesis delivery system and method for delivery of heart valve prosthesis with introducer sheath and loading system
CN110392557A (zh) 2017-01-27 2019-10-29 耶拿阀门科技股份有限公司 心脏瓣膜模拟
CN110174474B (zh) * 2019-05-24 2022-02-18 石家庄四药有限公司 复方电解质注射液(ⅱ)中l-苹果酸异构体的检测方法
CN112121051B (zh) * 2020-09-30 2021-06-18 郑州大学 莫扎伐坦在制备抗消化道肿瘤药物中的应用
US12171658B2 (en) 2022-11-09 2024-12-24 Jenavalve Technology, Inc. Catheter system for sequential deployment of an expandable implant

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH01102124A (ja) 1987-10-14 1989-04-19 Kubota Ltd コンクリート構造体支持構造
US5753677A (en) * 1989-10-20 1998-05-19 Otsuka Pharmaceutical Co., Ltd. Benzoheterocyclic compounds
WO1991005549A1 (en) 1989-10-20 1991-05-02 Otsuka Pharmaceutical Co., Ltd. Benzoheterocyclic compounds
US5258510A (en) 1989-10-20 1993-11-02 Otsuka Pharma Co Ltd Benzoheterocyclic compounds
AU657424B2 (en) 1992-07-02 1995-03-09 Otsuka Pharmaceutical Co., Ltd. Oxytocin antagonist
JPH0680641A (ja) 1992-09-01 1994-03-22 Otsuka Pharmaceut Co Ltd 光学活性な５−ヒドロキシベンゾアゼピン誘導体の製造法
TW354762B (en) 1993-02-23 1999-03-21 Otsuka Pharma Co Ltd Agent for prophylaxis or treatment of cataract
JP2694319B2 (ja) 1993-12-24 1997-12-24 大塚製薬株式会社 抗潰瘍剤
JP3002766B2 (ja) 1994-12-09 2000-01-24 大塚製薬株式会社 脳浮腫治療剤
JPH10120592A (ja) 1996-10-22 1998-05-12 Otsuka Pharmaceut Co Ltd メニエール病乃至メニエール症候群治療剤
JP4210355B2 (ja) * 1997-07-03 2009-01-14 大塚製薬株式会社 固形製剤組成物
WO2001054677A2 (en) 2000-01-26 2001-08-02 Warner-Lambert Company Ace inhibitor-vasopressin antagonist combinations
US20030103983A1 (en) * 2002-05-09 2003-06-05 Pressler Milton Lethan Ace inhibitor-vasopressin antagonist combinations
US20030008860A1 (en) * 2002-05-09 2003-01-09 Bakker-Arkema Rebecca Guggemos Treatment of congestive heart failure
EP1195166B1 (de) * 2000-10-04 2007-07-25 Astellas Pharma Inc. Verwendung von einem Vasopressin-Antagonisten wie Conivaptan zur Herstellung eines Medikaments für die Behandlung der pulmonalen Hypertension
TWI322689B (en) * 2003-02-24 2010-04-01 Otsuka Pharma Co Ltd Method for treating severe heart failure and medicament therefor

Also Published As

Publication number Publication date
NO335369B1 (no) 2014-12-01
EP1596868A4 (de) 2006-03-29
AU2004212842B9 (en) 2009-03-05
WO2004073716A1 (en) 2004-09-02
SI1596868T1 (sl) 2008-12-31
AR043259A1 (es) 2005-07-20
NO20050569D0 (no) 2005-02-02
RU2005102110A (ru) 2005-09-20
KR20050105972A (ko) 2005-11-08
DK1596868T3 (da) 2008-12-08
PL373432A1 (en) 2005-08-22
HK1084037A1 (zh) 2006-07-21
JP2006518731A (ja) 2006-08-17
RU2008133654A (ru) 2010-02-20
TWI322689B (en) 2010-04-01
AU2004212842A1 (en) 2004-09-02
PL404315A1 (pl) 2013-08-05
JP4771937B2 (ja) 2011-09-14
KR100706727B1 (ko) 2007-04-12
MY143740A (en) 2011-07-15
DE602004017283D1 (de) 2008-12-04
CA2493475A1 (en) 2004-09-02
MXPA05001623A (es) 2005-04-25
CN1700919A (zh) 2005-11-23
US20080214523A1 (en) 2008-09-04
RU2346689C2 (ru) 2009-02-20
ES2315640T3 (es) 2009-04-01
AU2009201109A1 (en) 2009-04-09
BRPI0405657A (pt) 2005-07-19
PL218069B1 (pl) 2014-10-31
JP2011148806A (ja) 2011-08-04
US20050187210A1 (en) 2005-08-25
EP1596868A1 (de) 2005-11-23
NO20050569L (no) 2005-11-22
US7749993B2 (en) 2010-07-06
EP1596868B1 (de) 2008-10-22
EP2000142A1 (de) 2008-12-10
PT1596868E (pt) 2009-01-14
CY1108583T1 (el) 2014-04-09
US7423032B2 (en) 2008-09-09
TW200418489A (en) 2004-10-01
AU2004212842B2 (en) 2009-01-08
CN100577171C (zh) 2010-01-06

Similar Documents

Publication Publication Date Title
EP1701664A4 (de) System und verfahren zur behandlung von gewebe
DE602004017283D1 (de) Verfahren zur behandlung von schwerer herzinsuffizienz und medikament dafür
EP1626730A4 (de) Verfahren, gerät und zusammensetzung zur behandlung von akne
EP1896083A4 (de) Verfahren zur behandlung von pompe-krankheit mit 1-desoxynojirimycin und derivaten
ATE489955T1 (de) Verfahren und zusammensetzung zur behandlung von peripheren gefässkrankheiten
EP1565230A4 (de) Materialzusammensetzungen und verwandtesysteme und verfahren zur behandlung von herzerkrankungen
DE602004021790D1 (de) Verfahren zur behandlung von parkinson-krankheit
EP1816990A4 (de) Systeme, vorrichtungen und verfahren zur behandlung von bandscheibenerkrankungen
DE602006019753D1 (de) Verfahren und gerät zur behandlung von aneurysmen der a. thoracica
DE60334517D1 (de) System und Verfahren zur Durchführung von am-Chip Selbsttests
DE602004023829D1 (de) Verfahren zur behandlung von sinuskopfschmerzen
DE602005011656D1 (de) Verfahren zur behandlung von dickdarmkrebs mit botulinum neurotoxin
DE602005008970D1 (de) Verfahren und zusammensetzungen zur behandlung von augenerkrankungen mit retinyl-derivaten
DE602004022036D1 (de) Verfahren zur behandlung von atherosklerose, dyslipidämie und verwandten erkrankungen und pharmazeutische zusammensetzungen
EP1635801A4 (de) Verfahren zur behandlung und prävention von herzarrhythmie
ATE474602T1 (de) Verfahren zur behandlung von hiv-infektion
EP1595852A4 (de) Verfahren zur behandlung von ammoniakalischen stickstoffenthaltendem wasser
EP1487480A4 (de) Fusionsmoleküle und verfahren zur behandlung von immunkrankheiten
DE60223688D1 (de) Verfahren zur behandlung von multiplem myelom
DE602004016712D1 (de) Vorrichtung und Verfahren zur Bestimmung von Blutkomponenten
DE602004001134D1 (de) Tetrazolderivate und verfahren zur behandlung von stoffwechselbedingten erkrankungen damit
EP1651237A4 (de) Verfahren zur behandlung von dermatologischen erkrankungen
EP1684735A4 (de) Verbindungen und verfahren zur behandlung und prävention von belastungsinduzierten herzarrhythmien
EP1592464A4 (de) Verfahren zur behandlung von kognitivem verfall aufgrund von schlafmangel und stress
DE602004010548D1 (de) Verfahren zur behandlung von tierhäuten

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1596868

Country of ref document: EP